Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-06-181414
Filing Date
2006-08-29
Accepted
2006-08-29 14:54:58
Documents
8
Period of Report
2006-06-30

Document Format Files

Seq Description Document Type Size
1 FOR THE FISCAL YEAR ENDED JUNE 30, 2006 d10k.htm 10-K 889353
2 DEVELOPMENT, COLLABORATION AND LICENSE AGREEMENT dex1025.htm EX-10.25 381582
3 SUBSIDIARIES OF THE COMPANY dex211.htm EX-21.1 2061
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - ERNST & YOUNG LLP dex231.htm EX-23.1 1837
5 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302(A) dex311.htm EX-31.1 6558
6 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302(A) dex312.htm EX-31.2 6777
7 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 906 dex321.htm EX-32.1 3473
8 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 906 dex322.htm EX-32.2 3651
  Complete submission text file 0001193125-06-181414.txt   1296685
Mailing Address 300 AMERICAN ROAD MORRIS PLAINS NJ 07950
Business Address 300 AMERICAN RD MORRIS PLAINS NJ 07950 9736058200
IMMUNOMEDICS INC (Filer) CIK: 0000722830 (see all company filings)

EIN.: 611009366 | State of Incorp.: DE | Fiscal Year End: 0825
Type: 10-K | Act: 34 | File No.: 000-12104 | Film No.: 061062145
SIC: 2835 In Vitro & In Vivo Diagnostic Substances